These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7595173)

  • 1. Pheochromocytoma in multiple endocrine neoplasia type 2: European study. The Euromen Study Group.
    Modigliani E; Vasen HM; Raue K; Dralle H; Frilling A; Gheri RG; Brandi ML; Limbert E; Niederle B; Forgas L
    J Intern Med; 1995 Oct; 238(4):363-7. PubMed ID: 7595173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study.
    Nguyen L; Niccoli-Sire P; Caron P; Bastie D; Maes B; Chabrier G; Chabre O; Rohmer V; Lecomte P; Henry JF; Conte-Devolx B;
    Eur J Endocrinol; 2001 Jan; 144(1):37-44. PubMed ID: 11174835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple endocrine neoplasia type 2A. Study of a family.
    Correia MJ; Lopes LO; Bugalho MJ; Cristina L; Santos AI; Bordalo AD; Pinho B; da Silva HL; Gonçalves MD; Ribeiro C; Tuna JL
    Rev Port Cardiol; 2000 Jan; 19(1):11-31. PubMed ID: 10731788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pheochromocytoma in MEN 2A syndrome. Study of 54 patients.
    Rodriguez JM; Balsalobre M; Ponce JL; Ríos A; Torregrosa NM; Tebar J; Parrilla P
    World J Surg; 2008 Nov; 32(11):2520-6. PubMed ID: 18795243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of RET Screening on the Management of Multiple Endocrine Neoplasia Type 2A: 10 Years Experience and Follow-Up in Three Families.
    Wang YP; Li FP; Wang HH; Fang XD; Zhu ZS; Chen YL; Qi XP
    Endocr Metab Immune Disord Drug Targets; 2022; 22(3):339-347. PubMed ID: 34445950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pheochromocytoma in Children and Adolescents With Multiple Endocrine Neoplasia Type 2B.
    Makri A; Akshintala S; Derse-Anthony C; Del Rivero J; Widemann B; Stratakis CA; Glod J; Lodish M
    J Clin Endocrinol Metab; 2019 Jan; 104(1):7-12. PubMed ID: 30113649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2.
    Thosani S; Ayala-Ramirez M; Palmer L; Hu MI; Rich T; Gagel RF; Cote G; Waguespack SG; Habra MA; Jimenez C
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1813-9. PubMed ID: 24030942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
    Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
    Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple endocrine neoplasia type 2A: case report.
    Păun DL; Poiană C; Petriş R; Radian S; Miulescu RD; Constantinescu G; Orban C
    Chirurgia (Bucur); 2013; 108(6):900-3. PubMed ID: 24331334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple endocrine neoplasia type 2.
    Lodish M
    Front Horm Res; 2013; 41():16-29. PubMed ID: 23652668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multiple endocrine neoplasia syndromes. Type 2].
    Juodele L; Juozaityte E; Zindzius A; Pundzius J
    Medicina (Kaunas); 2005; 41(4):281-94. PubMed ID: 15864001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple endocrine neoplasia 2A (MEN 2A) syndrome.
    Breza J; Breza J
    Bratisl Lek Listy; 2018; 119(2):120-125. PubMed ID: 29455549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and genetic profile of patients with medullary thyroid cancer treated in the Cancer Centre--Institute of Oncology in Warsaw].
    Czetwertyńska M; Kozłowicz-Gudzińska I; Stachlewska-Nasfeter E; Sromek M; Skasko E; Paszko Z
    Endokrynol Pol; 2006; 57(4):415-9. PubMed ID: 17006846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catecholamine crisis as a first manifestation of familial bilateral pheochromocytoma caused by RET proto-oncogene mutation in codon C 634R.
    Zwolak A; Rudzki G; Świrska J; Dudzińska M; Daniluk J; Tarach J
    Endokrynol Pol; 2015; 66(5):462-8. PubMed ID: 26457501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenalectomy for familial pheochromocytoma in the laparoscopic era.
    Brunt LM; Lairmore TC; Doherty GM; Quasebarth MA; DeBenedetti M; Moley JF
    Ann Surg; 2002 May; 235(5):713-20; discussion 720-1. PubMed ID: 11981218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers.
    Lebeault M; Pinson S; Guillaud-Bataille M; Gimenez-Roqueplo AP; Carrie A; Barbu V; Pigny P; Bezieau S; Rey JM; Delvincourt C; Giraud S; Veyrat-Durebex C; Saulnier P; Bouzamondo N; Chabbert M; Blin J; Mohamed A; Romanet P; Borson-Chazot F; Rohmer V; Barlier A; Mirebeau-Prunier D
    Thyroid; 2017 Dec; 27(12):1511-1522. PubMed ID: 28946813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral laparoscopic adrenalectomy followed by contralateral retroperitoneoscopic partial adrenalectomy in a patient with multiple endocrine neoplasia type 2a syndrome.
    Mugiya S; Suzuki K; Saisu K; Fujita K
    J Endourol; 1999 Mar; 13(2):99-104; discussion 104-6. PubMed ID: 10213103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical patterns and RET proto-oncogene identification of pheochromocytoma in 13 multiple endocrine neoplasia type 2A pedigrees].
    Qi XP; Chen ZG; Jin HY; Li F; Cheng J; Ying RB; Zhao JQ; Guo DG; Luo SY; Chen GP; Zhang XN
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2200-4. PubMed ID: 24169328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study.
    Mathiesen JS; Habra MA; Bassett JHD; Choudhury SM; Balasubramanian SP; Howlett TA; Robinson BG; Gimenez-Roqueplo AP; Castinetti F; Vestergaard P; Frank-Raue K
    J Clin Endocrinol Metab; 2017 Jun; 102(6):2069-2074. PubMed ID: 28323957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pheochromocytoma and medullary thyroid carcinoma in a pregnant multiple endocrine neoplasia-2A patient.
    Sarathi V; Bandgar TR; Menon PS; Shah NS
    Gynecol Endocrinol; 2011 Aug; 27(8):533-5. PubMed ID: 20672905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.